SEC Comment Letter 0000000000-23-006052 to AXIM BIOTECHNOLOGIES, INC. (AXIM) (CIK 0001514946) (AXIM)
AXIM BIOTECHNOLOGIES, INC. (AXIM) (CIK 0001514946)
Date: June 7, 2023 · CIK: 0001514946 · Accession: 0000000000-23-006052
AI Filing Summary & Sentiment
File numbers found in text: 333-272390
Letter
United States securities and exchange commission logo June 7, 2023 John Huemoeller President AXIM Biotechnologies, Inc. 6191 Cornerstone Court, E. Suite 114 San Diego, CA 92121 Re:AXIM Biotechnologies, Inc. Registration Statement on Form S-1 Filed June 2, 2023 File No. 333-272390 Dear John Huemoeller: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John Cleary
Show Raw Text
United States securities and exchange commission logo
June 7, 2023
John Huemoeller
President
AXIM Biotechnologies, Inc.
6191 Cornerstone Court, E. Suite 114
San Diego, CA 92121
Re:AXIM Biotechnologies, Inc.
Registration Statement on Form S-1
Filed June 2, 2023
File No. 333-272390
Dear John Huemoeller:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John Cleary